Expanding Access to Psychedelic Therapy Services

The chapter explores the process of bringing providers into a network to offer psychedelic therapy services, discussing criteria, credentialing, and expanding availability to reach 100,000 people by 2023. It highlights the interest from employers in offering psychedelic therapy as a benefit, the positive impact on mental health, and the growing trend of companies providing these services. The partnership with Dr. Bronner's is discussed, showcasing positive outcomes and the importance of determining coverage for ketamine and psychedelic therapy for employees.